Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ · Healthcare
Kiniksa Pharmaceuticals International, plc Shares Outstanding 2021–2025
Kiniksa Pharmaceuticals International, plc annual/quarterly shares outstanding history and growth rate from 2021 to 2026. Shares outstanding refers to a company's stock currently held by all its shareholders, including institutional investors and company insiders.
- Kiniksa Pharmaceuticals International, plc shares outstanding for the quarter ending March 31, 2026 was 0.08 B shs, a 8.23% increase year-over-year.
- Kiniksa Pharmaceuticals International, plc annual shares outstanding for 2025 was 0.08 B shs, a 10.58% increase from 2024.
- Kiniksa Pharmaceuticals International, plc annual shares outstanding for 2024 was 0.07 B shs, a 0.69% decrease from 2023.
- Kiniksa Pharmaceuticals International, plc annual shares outstanding for 2023 was 0.07 B shs, a 2.13% increase from 2022.
- Kiniksa Pharmaceuticals International, plc annual shares outstanding for 2022 was 0.07 B shs.
Shares Outstanding
ANNUAL · B SHS
QUARTERLY · B SHS
YEAR-OVER-YEAR GROWTH · %
Kiniksa Pharmaceuticals International, plc Shares Outstanding — FAQ
Kiniksa Pharmaceuticals International, plc (KNSA) shares outstanding over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
What is Kiniksa Pharmaceuticals International, plc's shares outstanding?
Kiniksa Pharmaceuticals International, plc (KNSA) reported shares outstanding of 0.08B shares for fiscal 2025.
Where can I see KNSA's shares outstanding history?
The chart and table above show Kiniksa Pharmaceuticals International, plc's shares outstanding by year and by quarter, including the growth rate.